Investorideas.com - UV Flu Technologies Receives Large UV-400 Air Purifier Order Directly Targeting Residential Marketplace

Investorideas.com - UV Flu Technologies Receives Large UV-400 Air Purifier Order Directly Targeting Residential Marketplace
OTCBB:UVFT


Visit this company: http://www.uvflutech.com/
CENTERVILLE, MA - September 29, 2010 (http://www.investorideas.com/ newswire, http://www.biotechindustrystocks.com/) - UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") is pleased to announce that the company has received an order for 100 UV-400 air purifying units from Semper Fi, a Long Island based distribution company which primarily markets to residential consumers.


The Distributor has advised that they are actively adding representatives to cover sales leads encompassing the Tri-State area. In response, the Company has ensured that an ample quantity of units to satisfy initial sales needs have been priority diverted for immediate shipment to the client.
"This order is significant because our product was principally designed for the commercial marketplace," said Jack Lennon, President of UV Fu Technologies. "Our UV-400 has been laboratory tested and proven to offer highly effective airborne bacteria-killing capabilities that will provide Semper Fi with a product truly superior to anything else currently in the marketplace."


Mr. Lennon continues, "We want to also note that in the residential market we have received feedback from the field where certain individuals have reported a dramatic difference in their respiratory issues in as little as 2-3 hours from starting their UV-400 at home. In the past month alone, we have received testimonials from consumers indicating that individuals with sleep disorders due to snoring have seen significant improvement while operating the unit in their bedroom at night. The Company makes no claims in this area, but is planning to follow up on these reports in order to determine if further study or future development in this area is warranted."
Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.bout UV Flu Technologies, Inc. (OTCBB: UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. ViraTech UV-400 is a Class II medical device and is available without a prescription.


Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.


ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.
John J. Lennon, President & CEO
Investor Information:Geaux IR Services, Inc.Toll-Free: 1-888-355-8838investors@uvflutech.com
SOURCE: UV Flu Technologies, Inc.


More Info:
Published at http://www.investorideas.com/ - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Connect with Investorideas.com
Publish Your News - Send a release
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp